' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

SENSE registry for status epilepticus.
Kellinghaus, C; Rossetti, AO; Trinka, E; Lang, N; Unterberger, I; Rüegg, S; Tilz, C; Uzelac, Z; Rosenow, F;
Epilepsia. 2018; 59 Suppl 2: 150-154.
Übersichtsarbeiten

PMU-Autor/inn/en

Trinka Eugen

Abstract

Evidence is scarce regarding the treatment of status epilepticus (SE). Only a few large randomized controlled trials have been published. Therefore, we set up a multicenter registry to prospectively document treatment practice in several different large hospitals in German-speaking countries. Over a period of more than 4 years, we were able to document 1179 episodes of 1049 patients who were treated for SE in 1 of the 8 participating centers in Germany, Austria, and Switzerland. Median age was 70 years. The most frequent etiology was remote (32%), followed by acute (31%), or a mixture of acute and remote factors (10%). Semiology was generalized convulsive in 44%, focal motor in 27%, and nonconvulsive in 30%. Only a few patients did not have relevant comorbidities. Median latency between SE onset and first treatment was 1 hour (median). Three hundred ninety-three (32%) of the patients were treated within 30 minutes after onset. The first treatment step consisted of benzodiazepines in more than 80%, and in levetiracetam in 15%. Five hundred eleven patients (49%) were refractory (defined as ongoing SE after application of benzodiazepine and 1 intravenous anticonvulsant). Further analysis of these registry data may be important for hypothesis generation and trial design for treatment of status epilepticus.


Find related publications in this database (Keywords)

registry
status epilepticus
therapy